Initial outcomes of a comprehensive care model for sickle cell disease among a tribal population in rural western India

Gayatri Desai; Kapil Kumar Dave; Somalee Banerjee; Palav Babaria; Reena Gupta

doi:10.18203/2394-6040.ijcmph20161399

Authors

Gayatri Desai SEWA Rural, Jhagadia, Bharuch
Kapil Kumar Dave SEWA Rural, Jhagadia, Bharuch
Somalee Banerjee Department of Internal Medicine, Kaiser Foundation Hospital, Oakland, CA
Palav Babaria Department of Medicine, Highland Hospital, Alameda Health System, Oakland, CA
Reena Gupta Department of General Internal Medicine, San Francisco General Hospital, University of California, San Francisco, CA

DOI:

https://doi.org/10.18203/2394-6040.ijcmph20161399

Keywords:

SCD, Comprehensive care model, Coverage of proven interventions, Tribal, Rural

Abstract

Background: Sickle cell disease (SCD) is the most prevalent inherited blood disorder worldwide, and is increasingly recognized as a neglected chronic disease. Several cost-effective interventions have dramatically reduced morbidity and mortality from SCD in developed countries. However, access to care for SCD in India is limited in most rural tribal regions with the highest SCD prevalence.

Methods:In 2014, we implemented a comprehensive care model in rural Gujarat, India, with the aim of providing high-quality screening and treatment to increase coverage of proven interventions for sickle cell disease. Components of the intervention include: new-born, antenatal and family screening; outpatient sickle cell clinic; inpatient protocols; chronic disease registry; and health education. We followed a cohort of patients enrolled between February 2014 and October 2014 and compared the severity of disease and coverage of proven interventions at baseline and after one year of follow-up.

Results: Of 164 patients diagnosed with sickle cell disease who enrolled in the comprehensive care program, 72 patients (43.9%) had SCD pain crises, 59 (35.9%) were hospitalized, 43 (26.2%) received blood transfusions, and 3 (1.8%) died during follow-up. Compared to baseline, coverage of pneumococcal vaccine (0.6% to 78.5%, p<0.001) and hydroxyurea (4.5% to 50.0%, p=0.002) significantly improved. There was a reduction in the proportion of patients with ≥3 pain crises per year (35.4% to 9.8%, p<0.001) and the proportion of patients with ≥1 hospitalization per year (56.7 go 36.0%, p<0.001) with no significant change in patients with ≥1 blood transfusion in last year (32.9% to 26.2%, p=0.127).

Conclusions:This study demonstrates that implementing a continuity care model for sickle cell disease in rural India is feasible and can improve coverage of evidence-based interventions.

Metrics

Metrics Loading ...

References

Pauling L, Itano HA, Singer SJ, Wells IC. Sickle cell anemia a molecular disease. Science.1949;110:543-8.

Piel FB, Patil AP, Howes RE, Nyangiri OA, Gething PW, Dewi M, et al. Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates. Lancet. 2013;381(9861):142-51.

Colah R, Mukherjee M, Ghosh K. Sickle cell disease in India. Curr Opin Hematol. 2014;21(3):215-23.

Colah RB, Mukherjee MB, Martin S, Ghosh K. Sickle cell disease in tribal populations in India. Indian J Med Res. 2015;141(5):509-15.

Patel J, Patel B, Gamit N, Serjeant GR. Screening for the sickle cell gene in Gujarat, India. A village-based model. J Community Genet. 2013;4(1):43-7.

Jain DL, Sarathi V, Upadhye D, Gulhane R, Nadkarni AH, Ghosh K, et al. Newborn screening shows a high incidence of sickle cell anemia in Central India. Hemoglobin. 2012;36:316-22.

Government of Gujarat. Sickle cell anaemia control project. Ahmedabad: Govt. of Gujarat, 2012. Available at http://nrhm.gujarat.gov.in/sickle-cell.htm. Accessed 7 July 2014.

Mukherjee MB, Surve RR, Ghosh K, Colah RB, Mohanty D. Clinical diversity of sickle cell disease in western india - influence of genetic factors. Acta Haematol. 2000;103(2):122-39.

Italia Y, Krishnamurti L, Mehta V, Raicha B, Italia K, Mehta P, et al. Feasibility of a new born Screening and Follow-up Programme for Sickle Cell Disease among South Gujarat, India. Tribal Populations. J Med Screen. 2014;22(1):1-7.

Upadhye DS, Jain DL, Trivedi YL, Nadkarni AH, Ghosh K, Colah RB. Neonatal screening and the clinical outcome in children with sickle cell disease in central India. PLoS One. 2016;11(1):e0147081.

Vichinsky E, Hurst D, Earles A, Kleman K, Lubin B. New born screening for sickle cell disease: effect on mortality. Pediatrics. 1988;81:749-55.

Gaston MH, Verter JI, Woods G, Pegelow C, Kelleher J, Presbury G, et al. Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial. N Engl J Med. 1986;314(25):1593-9.

Yanni E, Grosse SD, Yang Q, Olney RS. Trends in pediatric sickle cell disease-related mortality in the United States, 1983-2002. J Pediatr. 2009;154(4):541-5.

Lee A, Thomas P, Cupidore L, Serjeant B, Serjean G. Improved survival in homozygous sickle cell disease: lessons from a cohort study. Br Med J 1995;311:1600-2.

Tewari S, Rees D. Morbidity pattern of sickle cell disease in India: a single centre perspective IJMR. 2013;138:288-90.

SEWA Rural 2013 annual report, c2013. Available at:http://sewarural.org/sewa/wpcontent/uploads/2014/01/sr-ann-rpt-eng-332013-14.pdf. Accessed 23 October 2015.

Ferreira F, Chen S, Dabalen AL, Dikhanov YM, Nada H, Mitchell JD, et al. A global count of the extreme poor in 2012: data issues, methodology and initial results. Policy Research working paper; no. WPS 7432. Washington, D.C. World Bank Group, 2015. Available at: http://documents.worldbank.org/curated/en/2015/10/25114899/global-count-extreme-poor-2012-data-issues-methodology-initial-results. Accessed 2015.

Yawn BP, Buchanan GR, Afenyi-Annan AN, Ballas SK, Hassell KL, James AH, et al. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members. JAMA. 2014;312(10):1033-48.

Ghosh K, Colah R, Manglani M, Choudhry VP, Verma I, Madan N, et al. Guidelines for screening, diagnosis and management of hemoglobinopathies. Indian J Hum Genet. 2014;20(2):101-19.

The reliability of sickling and solubility tests and Peripheral blood film method for sickle cell disease Screening at district health centers in Uganda. Clin Mother Child Health. 2010;7(1):1205-10.

Italia K, Kangne H, Shanmukaiah C, Nadkarni AH, Ghosh K, Colah RB. Variable phenotypes of sickle cell disease in India with the Arab-Indian haplotype. Br J Haematol. 2015;168(1):156-9.